pharma

Global Drug Delivery Systems (DDS) Market Transforms Amid New Pharma Demands

FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Alira Health today released its 2025 Global Drug Delivery System Trends Report,…

2 months ago

Pharmacy Council of India Gives Nod to Chandigarh University, Uttar Pradesh to Launch Courses at School of Pharmacy

Chandigarh University, Uttar Pradesh, continues to break new ground in AI-augmented multidisciplinary education with a major milestone—its School of Pharmacy…

2 months ago

AscellaHealth Leaders Take the Stage at SIIA National Conference: Present Strategies for Managing High-Cost Claims and Building Pharma Partnerships

BERWYN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical…

2 months ago

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

October 03, 2025 16:01 ET  | Source: BridgeBio Pharma, Inc. PALO ALTO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio…

3 months ago

Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases

September 29, 2025 19:30 ET  | Source: Nxera Pharma Tokyo, Japan and Cambridge and London, UK, 30 September 2025 –…

3 months ago

Lenovo GOAST 4.0 Decodes Trillions of Cells, Accelerating Genome Analysis to 24 Minutes

Breakthrough high-performance computing solution delivers 3x higher throughput, cost efficiency, and faster life-saving discoveries NEW DELHI, Sept. 19, 2025 /PRNewswire/…

3 months ago

Nxera Pharma and Cancer Research UK Announce First Patient Dosed in Phase 2a Trial of Investigational Cancer Immunotherapy HTL0039732

HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist being investigated to treat a wide range of solid…

3 months ago

Athira Pharma Announces Reverse Stock Split

BOTHELL, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (“Athira” or “Company”) (NASDAQ: ATHA), a clinical stage biopharmaceutical…

3 months ago

Encaleret Showed Parathyroid Hormone-Independent Normalization of Blood and Urine Calcium in Phase 2 Proof-of-Concept Study in Post-Surgical Hypoparathyroidism

September 06, 2025 14:30 ET  | Source: BridgeBio Pharma, Inc. - 80% of post-surgical hypoparathyroidism participants achieved concomitant blood and…

3 months ago

Introducing Auryis AI-Powered Unified Compliance for Pharma & Life Sciences

BENGALURU, India, Aug. 25, 2025 /PRNewswire/ -- Canarys (ISIN: INE0QG301017) is proud to announce the launch of Auryis, their AI-powered, unified compliance…

4 months ago